228 related articles for article (PubMed ID: 442179)
21. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
22. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
[TBL] [Abstract][Full Text] [Related]
23. Duration of infection-derived immunity to cholera.
Levine MM; Black RE; Clements ML; Cisneros L; Nalin DR; Young CR
J Infect Dis; 1981 Jun; 143(6):818-20. PubMed ID: 7252264
[TBL] [Abstract][Full Text] [Related]
24. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid.
Pierce NF
Ciba Found Symp; 1976; (42):129-47. PubMed ID: 1086763
[TBL] [Abstract][Full Text] [Related]
25. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.
Pierce NF; Cray WC; Sircar BK
Infect Immun; 1978 Jul; 21(1):185-93. PubMed ID: 711314
[TBL] [Abstract][Full Text] [Related]
26. Immunity in cholera.
Ghosh AK
Indian J Pathol Bacteriol; 1974 Apr; 17(2):118-25. PubMed ID: 4455619
[No Abstract] [Full Text] [Related]
27. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
Bondre VP; Sinha VB; Srivastava BS
FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
[TBL] [Abstract][Full Text] [Related]
29. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
30. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
Kay RA; Ferguson A
Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
[TBL] [Abstract][Full Text] [Related]
31. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.
Migasena S; Pitisuttitham P; Supanaranond W; Desakorn V; Prayurahong B; Suntharasamai P
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):423-8. PubMed ID: 3217824
[No Abstract] [Full Text] [Related]
32. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
[TBL] [Abstract][Full Text] [Related]
33. Vibrio cholerae infection and acquired immunity in an adult rabbit model.
Guinée PA; Jansen WH; Peters PW
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Feb; 259(1):118-31. PubMed ID: 4002931
[TBL] [Abstract][Full Text] [Related]
34. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
Majumdar AS; Dutta P; Dutta D; Ghose AC
Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
[TBL] [Abstract][Full Text] [Related]
36. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization.
Pierce NF; Reynolds HY
J Immunol; 1974 Sep; 113(3):1017-23. PubMed ID: 4413777
[No Abstract] [Full Text] [Related]
37. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
Svennerholm AM
Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
[TBL] [Abstract][Full Text] [Related]
38. [Quantitative evaluation of Vibrio cholerae colonization and lymphocyte count in small intestine villi of rabbits immunized with vibrio and cholera toxin].
Efremov VE; Polotskiĭ IuE; Samostrel'skiĭ AIu; Vasser NR; Selivestrova VG
Zh Mikrobiol Epidemiol Immunobiol; 1982 Feb; (2):63-70. PubMed ID: 7090657
[TBL] [Abstract][Full Text] [Related]
39. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
[TBL] [Abstract][Full Text] [Related]
40. Serological studies in cholera infection in Calcutta (1966-67).
Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
